Over the last 7 days, the Biotech industry has risen 2.7%, driven by gains from Regeneron Pharmaceuticals of 5.6%. This takes the industry's 12 month performance to a gain of 15%. Earnings are forecast to grow by 30% annually.
Has the U.S. Biotech Industry valuation changed over the past few years?
Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
---|---|---|---|---|---|---|
Fri, 16 Aug 2024 | US$870.9b | US$113.2b | -US$36,254,285,538.64 | 22.2x | -24x | 7.7x |
Sun, 14 Jul 2024 | US$1.2t | US$164.5b | -US$28,119,714,352.84 | 29.4x | -42.5x | 7.3x |
Tue, 11 Jun 2024 | US$1.2t | US$164.5b | -US$26,797,092,425.07 | 28.1x | -43.3x | 7.1x |
Thu, 09 May 2024 | US$1.1t | US$164.6b | -US$26,520,766,232.38 | 24.3x | -42.5x | 6.8x |
Sat, 06 Apr 2024 | US$1.1t | US$164.4b | -US$23,433,178,577.03 | 25x | -47.8x | 6.8x |
Mon, 04 Mar 2024 | US$1.2t | US$167.9b | -US$21,330,880,627.75 | 15.9x | -56.4x | 7.2x |
Wed, 31 Jan 2024 | US$1.4t | US$204.7b | -US$22,654,596,727.00 | 17.8x | -63.8x | 7.1x |
Fri, 29 Dec 2023 | US$1.4t | US$204.9b | -US$22,192,805,164.00 | 19.9x | -62.8x | 6.8x |
Sun, 26 Nov 2023 | US$1.2t | US$204.8b | -US$22,013,452,568.00 | 18.6x | -55.7x | 6x |
Tue, 24 Oct 2023 | US$1.2t | US$207.5b | -US$13,040,981,709.00 | 16.2x | -93x | 5.8x |
Thu, 21 Sep 2023 | US$1.3t | US$207.5b | -US$12,879,934,249.00 | 16.5x | -99.1x | 6.1x |
Sat, 19 Aug 2023 | US$1.3t | US$207.6b | -US$12,299,327,844.00 | 17.4x | -102.8x | 6.1x |
Mon, 17 Jul 2023 | US$1.1t | US$186.7b | -US$15,968,283,125.00 | 12.9x | -71.1x | 6.1x |
Wed, 14 Jun 2023 | US$1.2t | US$186.1b | -US$15,943,311,093.00 | 11.8x | -73x | 6.3x |
Fri, 12 May 2023 | US$1.2t | US$191.8b | -US$11,762,653,395.00 | 14.4x | -98.3x | 6x |
Sun, 09 Apr 2023 | US$1.2t | US$216.8b | -US$5,729,497,835.00 | 14x | -203x | 5.4x |
Tue, 07 Mar 2023 | US$1.1t | US$199.1b | -US$4,903,297,889.00 | 16x | -233.9x | 5.8x |
Thu, 02 Feb 2023 | US$1.2t | US$204.0b | US$1.9b | 15.1x | 622.3x | 5.7x |
Sat, 31 Dec 2022 | US$1.1t | US$203.5b | US$1.7b | 14.3x | 663.2x | 5.6x |
Mon, 28 Nov 2022 | US$1.1t | US$202.3b | US$1.3b | 14.6x | 845.5x | 5.6x |
Wed, 26 Oct 2022 | US$1.1t | US$206.5b | US$5.5b | 16.4x | 198.7x | 5.3x |
Fri, 23 Sep 2022 | US$1.0t | US$206.2b | US$5.7b | 14.1x | 180.9x | 5x |
Sun, 21 Aug 2022 | US$1.1t | US$206.4b | US$7.3b | 16x | 147.7x | 5.2x |
Tue, 19 Jul 2022 | US$1.1t | US$211.3b | US$10.6b | 17.2x | 102.8x | 5.2x |
Thu, 16 Jun 2022 | US$937.2b | US$212.0b | US$10.9b | 15.1x | 86.2x | 4.4x |
Sat, 14 May 2022 | US$993.8b | US$212.0b | US$10.6b | 14.4x | 93.7x | 4.7x |
Mon, 11 Apr 2022 | US$1.3t | US$226.8b | US$14.3b | 18.8x | 92.1x | 5.8x |
Wed, 09 Mar 2022 | US$1.2t | US$221.8b | US$10.6b | 18.7x | 112.2x | 5.4x |
Fri, 04 Feb 2022 | US$1.2t | US$213.5b | US$5.5b | 21.7x | 225.8x | 5.8x |
Sun, 02 Jan 2022 | US$1.4t | US$212.1b | US$2.8b | 25.5x | 509.6x | 6.7x |
Tue, 30 Nov 2021 | US$1.5t | US$211.9b | US$3.1b | 24.9x | 470x | 7x |
Thu, 28 Oct 2021 | US$1.5t | US$195.7b | -US$3,085,811,125.00 | 24.1x | -478.2x | 7.5x |
Sat, 25 Sep 2021 | US$1.6t | US$196.4b | -US$2,406,343,544.00 | 24.9x | -657.2x | 8.1x |
Mon, 23 Aug 2021 | US$1.6t | US$197.0b | -US$1,662,914,785.58 | 22.3x | -956x | 8.1x |
-956x
Which industries have driven the changes within the U.S. Healthcare industry?
US Market | 4.04% | |
Healthcare | 2.65% | |
Biotech | 2.71% | |
Biotech | 2.71% |
Which companies have driven the market over the last 7 days?
Company | Last Price | 7D | 1Y | Valuation | |
---|---|---|---|---|---|
REGN Regeneron Pharmaceuticals | US$1.18k | 5.6% +US$6.7b | 47.5% | PE29.4x | |
ABBV AbbVie | US$193.40 | 1.6% +US$5.3b | 28.9% | PE64.5x | |
SGEN Seagen | US$228.74 | 4.5% +US$1.8b | 76.5% | PS18.8x | |
NTRA Natera | US$122.25 | 13.5% +US$1.8b | 135.2% | PS11.1x | |
BNTX BioNTech | US$87.25 | 8.3% +US$1.6b | -22.9% | PS7x |